NECTAR7 is a global minded company with a niche focus on cellular health. Our products are backed by science and thorough university testing for one essential objective: “Improve quality of life.”
Who we AreNECTAR7 was founded by a diverse team with backgrounds in business, finance, technology, science, distribution, and branding, NECTAR7 is proud to bring breakthrough products through exclusive relationships with leading innovators.
NECTAR7 was founded by a diverse team with backgrounds in business, finance, technology, science, distribution, and branding, NECTAR7 is proud to bring breakthrough products through exclusive relationships with leading innovators.
Mr. David D’Arcangelo is a founding member and CEO of NECTAR7, LLC. Mr. D’Arcangelo is a strategic planning and business development executive with a proven track record. Previously, Mr. D’Arcangelo served as President and Director of AMS Health Sciences, Inc., listed on the American Stock Exchange from November 2002 to May 2005. AMS employed 65 staff and over 2,500 sales associates to market over fifty nutritional products. In addition to securing financing, he transitioned AMS out of ephedra-based products and into performance-based nutrition and weight loss products. He holds a B.A. in Economics and Business from the University of Redlands (UofR) and was inducted into the U of R athletic hall of fame.
Dr. Schork is Director of Bioinformatics and Biostatistics at the Scripps Translational Science Institute; Director of Research, Scripps Genomic Medicine; and Professor, Department of Molecular and Experimental Medicine at The Scripps Research Institute. Dr. Schork’s interest and expertise is in the areas of quantitative human genetics and genomics, especially the design and implementation of methodologies used to dissect the genetic basis of complex traits and diseases. Prior to his appointments at Scripps, Dr. Schork was a Professor of Biostatistics and Psychiatry, and Co-Director of the Center for Human Genetics and Genomics at the University of California, San Diego from 2000-2007. From 1994-2000 Dr. Schork was an Associate Professor of Epidemiology and Biostatistics at Case Western Reserve University in Cleveland, Ohio and an Associate Professor of Biostatistics at Harvard University. Between 1999 and 2000 Dr. Schork took a leave of absence to conduct research as the Vice President of Statistical Genomics at the French Biotechnology company, Genset, where he helped guide efforts to construct the first high-density map of the human genome. Dr. Schork has been selected as a member of a number of scientific journal editorial boards, is a frequent participant in U.S. National Institutes of Health-related steering committees and review boards, and has also been on the advisory board of five companies. He is currently Director of the Bioinformatics and Biostatistics Core of the NIA-sponsored Longevity Consortium and a member of the NHGRI’s Genetic Association Information Network (GAIN) data analysis committee. Dr. Schork has published over 400 scientific articles and book chapters on the analysis of complex, multifactorial traits and diseases. Dr. Schork earned a B.A. in Philosophy, an M.A. in Philosophy, an M.A. in Statistics, and a Ph.D. in Epidemiology all from the University of Michigan in Ann Arbor, Michigan
Maria Espaldon is on the board of Managers at NECTAR7 and will be heading up the beverage sector for the Company as well as branding and marketing across all the operating entities. She has 35 years of experience ranging from start-ups to large companies such as Proctor & Gamble. At P&G, Maria worked across a broad range of brands and categories in both national and international scope. She was responsible for numerous brand start-ups and turnarounds in Asia and in her last assignment, led P&G’s Global Innovation Discovery Group Ms. Espaldon also co-founded and actively runs East West Private, a celebrity branding company. She has a solid reputation for turning businesses around and building long- term growth. Ms. Espaldon holds a B.S. in Management Engineering from Ateneo de Manila University.
Mr. Stallings is the President of NECTAR7 Media, LLC and a Manager of NECTAR7, LLC. He is the founder of Ninthlink, Inc a successful digital agency and has over 15 years’ experience in the development of channel marketing programs for both direct-to-consumer & business-to-business. Over his career, he has served as a strategic partner for companies requiring digital advertising & management programs. Mr. Stallings has successful relationships with large corporations that include Qualcomm, Jacuzzi Brands, Turn, Google, Looker and more. He holds a A.A., in Business Administration from Ventura College and a B.A. in Media and Multimedia Arts from National University. Mr. Stallings serves his community by participating in digital advertising events, sponsorships, teaching and has recently become a key alliance in the development of STEAM+ programs for grade school education.